Shandong Lukang Pharmaceutical Co Ltd (600789) — Financial Flexibility Index
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥68.41 Million (operating CF CN¥-6.39 Million minus capex CN¥74.80 Million) represents 0% of total liabilities (CN¥4.71 Billion). Check Shandong Lukang Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see how efficiently does Shandong Lukang Pharmaceutical Co Ltd generate cash.
Annual Financial Flexibility Index for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shandong Lukang Pharmaceutical Co Ltd. Explore Shandong Lukang Pharmaceutical Co Ltd (600789) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥1.04 Billion | CN¥698.17 Million | CN¥4.78 Billion | ▲ +60.3% |
| 2024 | 0.14x | CN¥682.00 Million | CN¥402.82 Million | CN¥5.04 Billion | ▼ -27.2% |
| 2023 | 0.19x | CN¥941.92 Million | CN¥604.01 Million | CN¥5.06 Billion | ▲ +11.3% |
| 2022 | 0.17x | CN¥872.74 Million | CN¥444.38 Million | CN¥5.22 Billion | ▲ +15.4% |
| 2021 | 0.14x | CN¥636.07 Million | CN¥149.33 Million | CN¥4.39 Billion | ▼ -39.5% |
| 2020 | 0.24x | CN¥937.67 Million | CN¥234.55 Million | CN¥3.91 Billion | ▼ -21.2% |
| 2019 | 0.30x | CN¥1.19 Billion | CN¥361.87 Million | CN¥3.92 Billion | ▼ -11.9% |
| 2018 | 0.35x | CN¥1.21 Billion | CN¥351.09 Million | CN¥3.50 Billion | ▲ +1.4% |
| 2017 | 0.34x | CN¥1.06 Billion | CN¥275.51 Million | CN¥3.10 Billion | ▲ +11.9% |
| 2016 | 0.30x | CN¥667.75 Million | CN¥296.23 Million | CN¥2.20 Billion | ▲ +164.5% |
| 2015 | 0.11x | CN¥242.92 Million | CN¥78.39 Million | CN¥2.11 Billion | ▲ +31.0% |
| 2014 | 0.09x | CN¥226.51 Million | CN¥108.56 Million | CN¥2.58 Billion | ▼ -56.0% |
| 2013 | 0.20x | CN¥486.85 Million | CN¥256.50 Million | CN¥2.44 Billion | ▲ +18.7% |
| 2012 | 0.17x | CN¥399.60 Million | CN¥115.20 Million | CN¥2.38 Billion | ▼ -45.6% |
| 2011 | 0.31x | CN¥552.10 Million | CN¥123.28 Million | CN¥1.79 Billion | ▼ -30.5% |
| 2010 | 0.44x | CN¥599.57 Million | CN¥308.88 Million | CN¥1.35 Billion | ▲ +53.7% |
| 2009 | 0.29x | CN¥269.06 Million | CN¥199.49 Million | CN¥930.38 Million | ▲ +1.2% |
| 2008 | 0.29x | CN¥285.97 Million | CN¥209.39 Million | CN¥1.00 Billion | ▲ +86.7% |
| 2007 | 0.15x | CN¥160.54 Million | CN¥137.30 Million | CN¥1.05 Billion | ▲ +96.7% |
| 2006 | 0.08x | CN¥78.36 Million | CN¥56.24 Million | CN¥1.01 Billion | ▼ -62.0% |
| 2005 | 0.21x | CN¥222.91 Million | CN¥161.64 Million | CN¥1.09 Billion | ▲ +25.6% |
| 2004 | 0.16x | CN¥196.34 Million | CN¥63.24 Million | CN¥1.20 Billion | ▼ -49.1% |
| 2003 | 0.32x | CN¥346.67 Million | CN¥167.42 Million | CN¥1.08 Billion | ▼ -31.5% |
| 2002 | 0.47x | CN¥515.53 Million | CN¥315.59 Million | CN¥1.10 Billion | ▲ +20.3% |
| 2001 | 0.39x | CN¥473.93 Million | CN¥270.43 Million | CN¥1.22 Billion | ▲ +62.4% |
| 2000 | 0.24x | CN¥273.00 Million | CN¥22.36 Million | CN¥1.14 Billion | ▲ +26.9% |
| 1999 | 0.19x | CN¥130.69 Million | CN¥35.12 Million | CN¥691.92 Million | ▼ -59.5% |
| 1998 | 0.47x | CN¥203.14 Million | CN¥46.18 Million | CN¥435.91 Million | — |